Publication | Closed Access

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Combinatorial ChemistryMedicinal ChemistryPotent Antiproliferative AgentMedicineBrafv600e KinasesNovel Quinoline/chalcone/1,2,4-triazole HybridsAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery